Medicinal Products

Serzyl 25 mikrograma/125 mikrograma po potisku, stlačeni inhalat, suspenzija

Name Serzyl 25 mikrograma/125 mikrograma po potisku, stlačeni inhalat, suspenzija
Former Name Sirdupla 25 mikrograma/125 mikrograma po potisku, stlačeni inhalat, suspenzija
Marketing Authorisation Number HR-H-254713416
Active Substance flutikazonpropionat, salmeterolksinafoat
Pharmaceutical Form stlačeni inhalat, suspenzija
Strength 25 mikrograma + 125 mikrograma
Packaging [MA Number for Packaging] 1 inhalator sa 120 doza, u kutiji  [HR-H-254713416-01]
Manufacturer McDermott Laboratories Limited, t/a Gerard Laboratories, Dublin 13, Irska
McDermott Laboratories Limited, t/a Mylan Dublin Respiratory, Dublin 13, Irska
Marketing Authorisation Holder Mylan Hrvatska d.o.o., Koranska 2, Zagreb, Hrvatska
Marketing Authorisation Date 16.10.2020
MA Period of Validity unlimited
Classification Number UP/I-530-09/19-02/154
Registration Number 381-12-01/38-20-04
Composition jedna odmjerna doza (potiskom preko ventila) sadrži: 25 mikrograma salmeterola (u obliku salmeterolksinafoata) i 125 mikrograma flutikazonpropionata. To odgovara isporučenoj dozi (preko nastavka za usta) od 21 mikrograma salmeterola i 110 mikrograma flutikazonpropionata
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code R03AK06
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Back